Global Biomaterials Market Report (2022 to 2031) – Players Include Carpenter Technology, Corbion, Evonik Industries, Royal DSM and Berkeley Advanced Biomaterials –

Global Biomaterials Market Report (2022 to 2031) – Players Include Carpenter Technology, Corbion, Evonik Industries, Royal DSM and Berkeley Advanced Biomaterials –

Global Biomaterials Market Report (2022 to 2031) – Players Include Carpenter Technology, Corbion, Evonik Industries, Royal DSM and Berkeley Advanced Biomaterials –

DUBLIN–(BUSINESS WIRE)–The “Biomaterials Global Market Report 2022” report has been added to’s offering.

This report provides strategists, marketers and senior management with the critical information they need to assess the global biomaterials market.

The global biomaterials market is expected to grow from $91.08 billion in 2021 to $103.18 billion in 2022 at a compound annual growth rate (CAGR) of 13.28%. The biomaterials market is expected to reach $180.36 billion in 2026 at a compound annual growth rate (CAGR) of 15.03%.

Companies Mentioned

  • Carpenter Technology Corporation
  • Corbion NV
  • Evonik Industries
  • Royal DSM
  • Berkeley Advanced Biomaterials

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis

Major players in the biomaterials market are Carpenter Technology Corporation, Corbion NV, Evonik Industries, Royal DSM, Berkeley Advanced Biomaterials, BASF SE, Zimmer Biomet, Johnson and Johnson, Invibio, Medtronic, Organogenesis Holdings Inc, Stryker, Wright Medical Group NV, 3M Healthcare, AdvanSource Biomaterials Corporation, Baxter, Covestro, Cam Bioceramics BV, Celanese Corporation, CoorsTek Inc, CeramTec, Victrex plc and Collagen Matrix Inc.

The biomaterials market consists of sales of biomaterials by entities (organizations, sole traders, and partnerships) that refer to natural or synthetic materials used in medical applications to support, enhance, or replace damaged tissue or a biological function. Biomaterials are manmade substances that can be utilized to support tissues or structures in the body.

The main types of biomaterials are metallic biomaterial, polymeric biomaterials, natural biomaterials and ceramics. The metallic biomaterial are a stainless steels, titanium alloys, and cobalt alloys used to provide internal support to biological tissues.

The metallic biomaterials are manmade systems that are utilized in joint replacements, dental implants, orthopedic fixations, and stents to offer internal support to biological tissues. Biomaterials have a wide application in cardiovascular, orthopedic, ophthalmology, dental, plastic surgery, wound healing, tissue engineering and neurological/central nervous system and are used in hospitals and clinics, ambulatory surgical centers and other end users.

North America was the largest region in the biomaterials market in 2021. The regions covered in the biomaterials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The biomaterials market research report is one of a series of new reports that provides biomaterials market statistics, including biomaterials industry global market size, regional shares, competitors with a biomaterials market share, detailed biomaterials market segments, market trends and opportunities, and any further data you may need to thrive in the biomaterials industry. This biomaterials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The rising incidence of cardiovascular diseases is driving the growth of the biomaterials market. Cardiovascular disorders are caused by high blood pressure, smoking, high cholesterol, inactivity, and other factors. The increase in the prevalence of cardiovascular disorders is mainly due to noncontagious diseases like diabetes, chronic respiratory illness, and heart attacks due to hypertension. Biomaterials such as heart valves, cardiopulmonary bypass system, stents, vascular grafts, complete artificial heart, and pacemakers are used as a healing mechanism for damaged and diseased heart tissue.

The strategic partnership is a key trend gaining popularity in the biomaterials market. Key companies are focusing on partnerships to develop new implants and combination devices based on biomaterials by leveraging each other’s expertise, technology, and resources. These partnerships are also focused on enhancing the adoption of biomaterials. Such partnerships enable companies to gain a competitive edge in the market and increase revenue

In January 2021, Evonik Industries AG, a German specialty chemicals company acquired the LACTEL business of biodegradable polymers from DURECT Corporation for $15 million. With this acquisition, Evonik aims to expand in fast-growing markets such as biomaterials for tissue engineering, advanced drug delivery, and the 3D printing of implantable medical devices. DURECT Corporation is a US-based specialty pharmaceutical company.

The countries covered in the biomaterials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA.

For more information about this report visit


Laura Wood, Senior Press Manager

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900